Repeats in the kringle IV encoding domains in the Apo(a) gene and serum lipoprotein(a) level do not contribute to the risk for avascular necrosis of the bone (AVN) in pediatric acute lymphoblastic leukemia [2]

Leukemia

Volumn 20, Issue 5, 2006, Pages 879-880

  van Beek, R D ^a   Bezemer, D D L ^a   Meijerink, J P P ^a   de Muinck Keizer Schrama, S M P F ^a   Haas, O A ^b   te Winkel, L ^a   Pieters, R ^a   van den Heuvel Eibrink, M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; DEXAMETHASONE; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; TRIACYLGLYCEROL; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AVASCULAR NECROSIS; CAUCASIAN; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENETIC CODE; HIGH RISK PATIENT; HUMAN; KRINGLE DOMAIN; LABORATORY TEST; LETTER; LIPOPROTEIN BLOOD LEVEL; MALE; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK ASSESSMENT; SYMPTOMATOLOGY;

EID: 33646129473     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404161     Document Type: Letter

References (9)

1. Mattano Jr LA, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: A report from the Children's Cancer Group. J Clin Oncol 2000; 18: 3262-3272.
2. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002; 32: 94-124.
3. Berger CE, Kluger R, Urban M, Kowalski J, Haas OA, Engel A. Elevated levels of lipoprotein(a) in familial bone marrow edema syndrome of the hip. Clin Orthop 2000; 377: 126-131.
4. Utermann G. Lipoprotein(a). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic & Molecular Bases of Inherited Disease, 8th edn. McGraw-Hill: New York, 2001, pp 2753-2787.
5. Kraft HG, Kochl S, Menzel HJ, Sandholzer C, Utermann G. The apolipoprotein (a) gene: A transcribed hypervariable locus controlling plasma lipoprotein (a) concentration. Hum Genet 1992; 90: 220-230.
6. Glueck CJ, Crawford A, Roy D, Freiberg R, Glueck H, Stroop D. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg Am 1996; 78: 3-13.
7. Posan E, Szepesi K, Gaspar L, Csernatony Z, Harsfalvi J, Ajzner E et al. Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head. Blood Coagul Fibrinolysis 2003; 14: 243-248.
8. Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y. Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum 2004; 50: 3387-3391.
9. Relling MV, Yang W, Das S, Cook EH, Rosner GL, Neel M et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 2004; 22: 3930-3936.